Vaccines
US COVID-19 Deaths Surpass One Million Amid Concer
US COVID-19 Deaths Surpass One Million Amid Concerns Over Rising Cases

The US surpasses one million deaths from COVID-19 as daily case counts rise amidst the lifting of mask mandates and limited access to additional vaccine doses, highlighting ongoing challenges in pandemic control and mitigation efforts.

January 2023

Additional Approach Demonstrates Effectiveness of
Additional Approach Demonstrates Effectiveness of COVID-19 Vaccines in Reducing Pneumonia

Assessment of pneumonia chest CT scans provides an additional approach to demonstrating the effectiveness of different COVID-19 vaccines in reducing the risk of severe respiratory complications, complementing existing clinical trial data.

January 2023

CDC Recommends Booster Shots for Children Ages 5 t
CDC Recommends Booster Shots for Children Ages 5 to 11, along with Two Boosters for Adults over 50 and Immunocompromised Individuals

The CDC recommends booster shots for children ages 5 to 11, administered five months after their initial COVID-19 vaccination series, in addition to two booster doses for adults over 50 and immunocompromised individuals, aiming to enhance vaccine-induced immunity and protect vulnerable populations against severe COVID-19 outcomes.

January 2023

SARS-CoV-2 Infections Among Vaccinated Adults With
SARS-CoV-2 Infections Among Vaccinated Adults With Psychiatric Disorders

Individuals with psychiatric disorders are at increased risk of SARS-CoV-2 infection, emphasizing the importance of targeted preventive strategies and vaccination efforts in this vulnerable population.

January 2023

Unvaccinated Individuals Contribute Disproportiona
Unvaccinated Individuals Contribute Disproportionately to SARS-CoV-2 Risk for Vaccinated Population

Decisions made by unvaccinated individuals significantly contribute to the risk of SARS-CoV-2 transmission among vaccinated populations, underscoring the collective responsibility and impact of vaccination efforts on public health outcomes.

December 2022

Subcutaneous Injection Switch May Alleviate Fatigu
Subcutaneous Injection Switch May Alleviate Fatigue After COVID-19 Vaccination, Mice Study Suggests

Experiments in mice suggest that switching from intramuscular to subcutaneous injection may relieve fatigue commonly associated with COVID-19 vaccination, offering a potential strategy to improve post-vaccination tolerability in humans.

December 2022

High Seroprevalence of SARS-CoV-2 Antibodies Indic
High Seroprevalence of SARS-CoV-2 Antibodies Indicates Widespread Infection

Seroprevalence studies reveal a high prevalence of SARS-CoV-2 antibodies among Americans, indicating widespread infection with the Omicron variant and highlighting the need for continued vaccination efforts and public health interventions.

December 2022

Increase in COVID-19 Infections Among American Chi
Increase in COVID-19 Infections Among American Children During Omicron Wave

Infections among very young American children doubled during the Omicron wave, underscoring the need for continued vigilance and comprehensive vaccination strategies to protect vulnerable populations against COVID-19.

December 2022

Meningitis Vaccines Could Improve Protection Again
Meningitis Vaccines Could Improve Protection Against Gonorrhea

Meningitis vaccines may confer cross-protection against gonorrhea, offering a potential strategy to enhance immune responses and reduce the global burden of gonorrhea amidst rising cases and antibiotic resistance.

December 2022

Single Dose of Human Papillomavirus Vaccine Demons
Single Dose of Human Papillomavirus Vaccine Demonstrates Protective Efficacy

A single dose of the human papillomavirus (HPV) vaccine shows protective efficacy against cervical cancer, offering a simplified vaccination schedule and facilitating immunization efforts to reduce HPV-related morbidity and mortality.

December 2022